A study shows how scientists can control cell division on demand outside of a living system. The work is a significant leap forward that can enhance our grasp of human biology and disease.

A living cell is a bustling metropolis, with countless molecules and proteins navigating crowded spaces in every direction.

Celcuity's lead asset, Gedatolisib, is a dual PI3K/mTOR inhibitor targeting various cancers, currently in multiple Phase 3 ...

By Katherine Schulten Weekly Student News Quiz: Election Day, World Series, Floods Have you been paying attention to current events recently? See how many of these 10 questions you can get right.

November 5th to 10th, Greenway(SHSE:688345), a global leader in micromobility lithium battery solutions , showcased its ...

LIVERMORE, California and TOKYO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- FormFactor, Inc. (NASDAQ: FORM) and Advantest Corporation (TSE: 6857) announced today a strategic partnership to develop a novel test ...

Swiss scientists have successfully created 3D cell models using lip cells. This achievement, a first in the world, could potentially revolutionize the treatment of lip injuries and infections.

Expansion of Phase 1 CALiPSO-1 trial of CNTY-101 in autoimmune disease to include diffuse cutaneous systemic sclerosis and idiopathic ...

ICER has given tabelecleucel a rating of A, indicating the T cell therapy for Epstein-Barr virus related post-transplant ...

Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advancing ...

It feels like the Splinter Cell remake has been on its way for a decent while now, which isn't helped by the fact it's been over two years since we heard anything official about the game.

Shibaura Machine and its Italian technology partner EPF are showcasing an integrated, turnkey system for the plastic ...